펀드 보유
Baker Bros. Advisors — SEC 13F
2026. 6. 30. 기준 · 과거 시점 자료
제출일 · 2026. 8. 14.
These are the investment manager’s reported positions, not the named person’s personal brokerage holdings. Form 13F shows reportable long securities at quarter-end and omits cash, short positions and many foreign/private assets. Showing 83 of 83 reported share positions; full filings are linked. 1 option, principal-amount or warrant/debt rows are excluded. Option figures describe underlying exposure, not option premiums. Allocation is within the reported non-option share positions, not total fund assets. 13F does not disclose purchase costs or actual P&L.
| 종목 | 비중 | 주식 수 | 취득 원가 | 시장 가치 | 미실현 손익 |
|---|---|---|---|---|---|
| CUSIP 45337C102Incyte Corporation — COM | 17.54% | 30,762,330 | 미공개 | US$3,487,217,729.002026. 6. 30. | 미공개 |
| CUSIP 07725L102BeOne Medicines Ltd. — SPONSORED ADS | 12.61% | 8,801,567 | 미공개 | US$2,508,182,548.002026. 6. 30. | 미공개 |
| CUSIP 76155X100Revolution Medicines, Inc. — COM | 10.78% | 11,443,357 | 미공개 | US$2,143,111,899.002026. 6. 30. | 미공개 |
| CUSIP 558868105Madrigal Pharmaceuticals, Inc. — COM | 5.79% | 2,143,131 | 미공개 | US$1,150,754,190.002026. 6. 30. | 미공개 |
| CUSIP 004225108ACADIA Pharmaceuticals Inc. — COM | 5.46% | 42,912,904 | 미공개 | US$1,085,696,471.002026. 6. 30. | 미공개 |
| CUSIP 501575104Kymera Therapeutics, Inc. — COM | 4.99% | 8,657,242 | 미공개 | US$992,725,940.002026. 6. 30. | 미공개 |
| CUSIP 457669307Insmed Incorporated — COM PAR $.01 | 4.72% | 8,796,111 | 미공개 | US$937,841,355.002026. 6. 30. | 미공개 |
| CUSIP 15102K100Celcuity Inc. — COM | 4.16% | 7,915,792 | 미공개 | US$828,150,159.002026. 6. 30. | 미공개 |
| CUSIP 50015M109Kodiak Sciences Inc. — COM | 3.9% | 19,919,186 | 미공개 | US$776,051,487.002026. 6. 30. | 미공개 |
| CUSIP 76243J105Rhythm Pharmaceuticals, Inc. — COM | 3.13% | 5,604,483 | 미공개 | US$622,265,747.002026. 6. 30. | 미공개 |
| CUSIP 74006W207Praxis Precision Medicines, Inc. — COM | 2.95% | 1,753,198 | 미공개 | US$586,953,158.002026. 6. 30. | 미공개 |
| CUSIP G01767105Alkermes plc — SHS | 2.64% | 10,012,267 | 미공개 | US$524,592,729.002026. 6. 30. | 미공개 |
| CUSIP 86627T108Summit Therapeutics Inc. — COM | 2.4% | 32,786,348 | 미공개 | US$477,697,090.002026. 6. 30. | 미공개 |
| CUSIP 384747101GRAIL, Inc. — COM | 1.38% | 4,028,614 | 미공개 | US$275,033,478.002026. 6. 30. | 미공개 |
| CUSIP 00288U106AbCellera Biologics Inc. — COM | 1.3% | 33,012,138 | 미공개 | US$259,145,283.002026. 6. 30. | 미공개 |
| CUSIP 45258J102Immunovant, Inc. — COM | 1.05% | 5,435,220 | 미공개 | US$209,419,027.002026. 6. 30. | 미공개 |
| CUSIP 45166A102IDEAYA Biosciences, Inc. — COM | 0.94% | 5,010,030 | 미공개 | US$186,723,818.002026. 6. 30. | 미공개 |
| CUSIP G52694109Kiniksa Pharmaceuticals International, plc — ORD SHS CL A | 0.91% | 2,834,643 | 미공개 | US$181,275,420.002026. 6. 30. | 미공개 |
| CUSIP G76279101Roivant Sciences Ltd. — SHS | 0.84% | 4,716,831 | 미공개 | US$166,928,649.002026. 6. 30. | 미공개 |
| CUSIP 04280A100Arrowhead Pharmaceuticals, Inc. — COM | 0.82% | 1,992,783 | 미공개 | US$162,431,742.002026. 6. 30. | 미공개 |
| CUSIP 462222100Ionis Pharmaceuticals, Inc. — COM | 0.82% | 2,047,727 | 미공개 | US$162,364,274.002026. 6. 30. | 미공개 |
| CUSIP 28036F105Edgewise Therapeutics, Inc. — COM | 0.76% | 3,701,719 | 미공개 | US$150,400,843.002026. 6. 30. | 미공개 |
| CUSIP 76029N106Replimune Group, Inc. — COM | 0.61% | 11,045,336 | 미공개 | US$122,271,870.002026. 6. 30. | 미공개 |
| CUSIP 67080M103Nurix Therapeutics, Inc. — COM | 0.57% | 4,658,556 | 미공개 | US$113,016,569.002026. 6. 30. | 미공개 |
| CUSIP 86150R107Stoke Therapeutics, Inc. — COM | 0.55% | 3,336,697 | 미공개 | US$109,176,726.002026. 6. 30. | 미공개 |
| CUSIP 61225M102Monte Rosa Therapeutics, Inc. — COM | 0.53% | 4,345,736 | 미공개 | US$105,166,811.002026. 6. 30. | 미공개 |
| CUSIP N44445109Immatics N.V. — SHS | 0.48% | 9,508,565 | 미공개 | US$96,321,763.002026. 6. 30. | 미공개 |
| CUSIP 24823R105Denali Therapeutics Inc. — COM | 0.48% | 3,734,336 | 미공개 | US$96,047,122.002026. 6. 30. | 미공개 |
| CUSIP 22663K107Crinetics Pharmaceuticals, Inc. — COM | 0.44% | 2,351,465 | 미공개 | US$87,991,820.002026. 6. 30. | 미공개 |
| CUSIP 252828108Dianthus Therapeutics, Inc. — COM | 0.42% | 852,164 | 미공개 | US$83,068,947.002026. 6. 30. | 미공개 |
| CUSIP 86366E106Structure Therapeutics Inc. — SPONSORED ADS | 0.39% | 1,432,529 | 미공개 | US$76,883,831.002026. 6. 30. | 미공개 |
| CUSIP 75383L102Rapport Therapeutics, Inc. — COM | 0.32% | 1,547,090 | 미공개 | US$64,467,240.002026. 6. 30. | 미공개 |
| CUSIP 022307102Alumis Inc. — COM | 0.28% | 2,012,500 | 미공개 | US$56,631,750.002026. 6. 30. | 미공개 |
| CUSIP 74065P101Prelude Therapeutics Inc. — COM | 0.27% | 10,123,824 | 미공개 | US$53,959,982.002026. 6. 30. | 미공개 |
| CUSIP 75943R102Relay Therapeutics, Inc. — COM | 0.27% | 2,826,783 | 미공개 | US$52,889,110.002026. 6. 30. | 미공개 |
| CUSIP 604749101Mirum Pharmaceuticals, Inc. — COM | 0.26% | 445,975 | 미공개 | US$52,210,293.002026. 6. 30. | 미공개 |
| CUSIP 088786108Bicycle Therapeutics plc — SPONSORED ADS | 0.23% | 10,885,357 | 미공개 | US$46,153,914.002026. 6. 30. | 미공개 |
| CUSIP 29337E102Enliven Therapeutics, Inc. — COM | 0.23% | 905,191 | 미공개 | US$45,938,443.002026. 6. 30. | 미공개 |
| CUSIP 15117B202Celldex Therapeutics, Inc. — COM | 0.22% | 1,182,611 | 미공개 | US$44,004,955.002026. 6. 30. | 미공개 |
| CUSIP 92790C104Viridian Therapeutics, Inc. — COM | 0.22% | 2,383,025 | 미공개 | US$43,776,169.002026. 6. 30. | 미공개 |
| CUSIP 25056L103Design Therapeutics, Inc. — COM | 0.19% | 2,678,430 | 미공개 | US$38,756,882.002026. 6. 30. | 미공개 |
| CUSIP 29384C108Entrada Therapeutics, Inc. — COM | 0.19% | 5,072,730 | 미공개 | US$37,335,293.002026. 6. 30. | 미공개 |
| CUSIP 81728A207Faeth Therapeutics, Inc. — COM | 0.16% | 1,286,411 | 미공개 | US$32,160,275.002026. 6. 30. | 미공개 |
| CUSIP 01021M104Aktis Oncology, Inc. — COM | 0.16% | 996,351 | 미공개 | US$32,112,393.002026. 6. 30. | 미공개 |
| CUSIP 64135M105Neurogene Inc. — COM | 0.16% | 991,691 | 미공개 | US$31,188,682.002026. 6. 30. | 미공개 |
| CUSIP 008064206Jade Biosciences, Inc. — COM | 0.14% | 1,230,426 | 미공개 | US$27,340,066.002026. 6. 30. | 미공개 |
| CUSIP 877619106Taysha Gene Therapies, Inc. — COM SHS | 0.14% | 4,004,756 | 미공개 | US$27,272,388.002026. 6. 30. | 미공개 |
| CUSIP 03969F109Arcus Biosciences, Inc. — COM | 0.13% | 844,816 | 미공개 | US$26,045,677.002026. 6. 30. | 미공개 |
| CUSIP 254604101Disc Medicine, Inc. — COM | 0.13% | 349,657 | 미공개 | US$25,573,913.002026. 6. 30. | 미공개 |
| CUSIP 00091E109Absci Corporation — COM | 0.12% | 2,134,803 | 미공개 | US$24,742,367.002026. 6. 30. | 미공개 |
| CUSIP 370920100Generate Biomedicines, Inc. — COM SHS | 0.12% | 1,423,602 | 미공개 | US$24,016,166.002026. 6. 30. | 미공개 |
| CUSIP 23306J309DBV Technologies S.A. — SPONSORED ADS | 0.12% | 1,461,425 | 미공개 | US$23,967,370.002026. 6. 30. | 미공개 |
| CUSIP 98420N105Xenon Pharmaceuticals Inc. — COM | 0.11% | 370,208 | 미공개 | US$22,345,755.002026. 6. 30. | 미공개 |
| CUSIP 878972108Tectonic Therapeutic, Inc. — COM | 0.11% | 607,788 | 미공개 | US$20,892,713.002026. 6. 30. | 미공개 |
| CUSIP 157085101Cerus Corporation — COM | 0.09% | 6,395,431 | 미공개 | US$18,674,659.002026. 6. 30. | 미공개 |
| CUSIP 23284F105CytomX Therapeutics, Inc. — COM | 0.09% | 4,975,826 | 미공개 | US$18,659,348.002026. 6. 30. | 미공개 |
| CUSIP 26818M108Dyne Therapeutics, Inc. — COM | 0.09% | 813,449 | 미공개 | US$18,066,702.002026. 6. 30. | 미공개 |
| CUSIP 23282W605Cytokinetics, Incorporated — COM | 0.09% | 211,267 | 미공개 | US$17,997,836.002026. 6. 30. | 미공개 |
| CUSIP 98401F105Xencor, Inc. — COM | 0.09% | 1,102,106 | 미공개 | US$17,743,907.002026. 6. 30. | 미공개 |
| CUSIP 829401108Sionna Therapeutics, Inc. — COM | 0.09% | 400,000 | 미공개 | US$17,596,000.002026. 6. 30. | 미공개 |
| CUSIP 45826J105Intellia Therapeutics, Inc. — COM | 0.08% | 930,232 | 미공개 | US$15,739,525.002026. 6. 30. | 미공개 |
| CUSIP 698955101Parabilis Medicines, Inc. — COM | 0.07% | 500,000 | 미공개 | US$13,685,000.002026. 6. 30. | 미공개 |
| CUSIP 56565P103MapLight Therapeutics, Inc. — COM | 0.07% | 364,705 | 미공개 | US$13,071,027.002026. 6. 30. | 미공개 |
| CUSIP 05348Y105Avalyn Pharma Inc. — COM SHS | 0.06% | 350,000 | 미공개 | US$11,522,000.002026. 6. 30. | 미공개 |
| CUSIP 30054Y107Evommune, Inc. — COM SHS | 0.06% | 847,390 | 미공개 | US$11,261,813.002026. 6. 30. | 미공개 |
| CUSIP 09075V102BioNTech SE — SPONSORED ADS | 0.06% | 119,743 | 미공개 | US$11,142,086.002026. 6. 30. | 미공개 |
| CUSIP 87583X109Tango Therapeutics, Inc. — COM | 0.05% | 333,333 | 미공개 | US$10,419,990.002026. 6. 30. | 미공개 |
| CUSIP 05338F306Avalo Therapeutics, Inc. — COM | 0.05% | 550,000 | 미공개 | US$10,164,000.002026. 6. 30. | 미공개 |
| CUSIP 81749D107Sera Prognostics, Inc. — CLASS A COM | 0.05% | 5,498,170 | 미공개 | US$10,006,669.002026. 6. 30. | 미공개 |
| CUSIP 92337C203Verastem, Inc. — COM | 0.05% | 2,499,338 | 미공개 | US$9,547,471.002026. 6. 30. | 미공개 |
| CUSIP 786700104Sagimet Biosciences Inc. — COM SER A | 0.04% | 952,996 | 미공개 | US$7,366,659.002026. 6. 30. | 미공개 |
| CUSIP 282564103Eikon Therapeutics, Inc. — COM | 0.04% | 555,555 | 미공개 | US$7,249,993.002026. 6. 30. | 미공개 |
| CUSIP 50180M108LB Pharmaceuticals Inc. — COM SHS | 0.03% | 200,000 | 미공개 | US$6,491,000.002026. 6. 30. | 미공개 |
| CUSIP 918385204vTv Therapeutics, Inc. — CL A | 0.03% | 148,314 | 미공개 | US$5,584,022.002026. 6. 30. | 미공개 |
| CUSIP Y95308105Wave Life Sciences Ltd. — SHS | 0.02% | 822,638 | 미공개 | US$4,779,527.002026. 6. 30. | 미공개 |
| CUSIP 74365U107Protara Therapeutics, Inc. — COM STK | 0.02% | 971,614 | 미공개 | US$3,711,565.002026. 6. 30. | 미공개 |
| CUSIP 89854M101TScan Therapeutics, Inc. — COM | 0.01% | 2,784,792 | 미공개 | US$2,729,375.002026. 6. 30. | 미공개 |
| CUSIP 45257U108Immunome, Inc. — COM | 0.01% | 55,306 | 미공개 | US$1,171,934.002026. 6. 30. | 미공개 |
| CUSIP 83086J200Skye Bioscience, Inc. — COM | 0.01% | 1,575,243 | 미공개 | US$1,092,116.002026. 6. 30. | 미공개 |
| CUSIP 799566104Sana Biotechnology, Inc. — COM | 0.01% | 310,483 | 미공개 | US$1,083,586.002026. 6. 30. | 미공개 |
| CUSIP 01626L204Aligos Therapeutics, Inc. — COM | 0% | 83,055 | 미공개 | US$479,227.002026. 6. 30. | 미공개 |
| CUSIP 90240B106Tyra Biosciences, Inc. — COM | 0% | 10,607 | 미공개 | US$338,788.002026. 6. 30. | 미공개 |
| CUSIP 86889P117Surrozen, Inc. Warrants @ $172.50 8/11/2026 (15 FOR 1) — W EXP 8/11/2026 | 0% | 833,333 | 미공개 | US$13,750.002026. 6. 30. | 미공개 |
포트폴리오 일부만 공개됨
종목별 손익에는 공개된 취득 원가와 동일 통화의 날짜가 명시된 평가액이 필요합니다. 배당 및 실현 이익을 제외한 미실현 가격 손익입니다. 누락된 값은 추정하지 않습니다.
